News  

Renovion, Inc., a clinical-stage pharmaceutical company focused on developing treatments for rare, chronic, and serious lung diseases...

Renovion, a UNC-affiliated startup, advances a breakthrough therapy to restore lung health and quality of life in patients with diseases...

Exploristics is pleased to announce today a collaboration with Renovion using Exploristics’ innovative study simulation software platform...

Renovion and the COPD Foundation have announced the creation of a new partnership to accelerate the development of a novel therapy for...

Renovion, Inc., a biopharmaceutical company on a mission to transform the treatment of chronic inflammatory lung diseases, announced the...

Renovion, Inc., a biopharmaceutical company on a mission to transform the lives of patients with chronic lung diseases characterized by...

Poised for pivotal lung transplant trial in U.S. Renovion, Inc., a biopharmaceutical company on a mission to transform the treatment of...

Renovion, Inc., a privately-held biopharmaceutical company developing novel therapeutics for respiratory diseases, including lung...

Renovion, Inc. ("Renovion"), an early stage drug development company targeting a novel treatment for lung transplant patients and other...